Sciele Pharma, Inc.
Sciele Pharma Announces FDA Approval of New Sular(R) Formulation
Published in Medical Letter on the CDC and FDA, January 20th, 2008
Sciele Pharma, Inc. (NASDAQ: SCRX) announced that the U.S. Food & Drug Administration (FDA) has approved all four dosage strengths of the new Sular(R) formulation. The new Sular formulation, which utilizes SkyePharma's (LSE:SKP) patented GEOMATRIX(TM) technology, provides a lower dose of Sular for each of its current doses. The Company expects to launch the new Sular formulation during the first quarter of 2008.
Patrick Fourteau, Chief Executive Officer of Sciele Pharma, said, "We are excited about this approval by the FDA for the new Sular formulation. This validates our product development and regulatory capabilities, as we have become a fully integrated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Clinical Research
Investigators at Mayo Clinic publish new data on clinical research - Clinical Trial Research
Recent findings in clinical trial research described by researchers from University of Washington - Clinical Trial Research
Research from D.A. Revicki and co-researchers in the area of clinical trial research published - Colon Cancer
Yale University details research in colon cancer - Immunization
Hawaii Biotech Receives Allowance to Perform West Nile Vaccine Clinical Trials - Ovarian Cancer
University of Mississippi publishes research in ovarian cancer - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
